Introduction stem cell therapy (SCT) is a promising and prospective approach in the treatment of patients with severe peripheral arterial disorders,mainly with Buergers disease.However,very little is known about the duration of the efficacy of SCT,and to our best knowledge very few data are available on the effectivity and safety of repeated SCT in patients with Buergers disease.